Archive for April 16th, 2010

FAS/FAZ Seeing Record 2010 Trading Volume (FAS, FAZ, GS)

You know the news on Goldman Sachs Group Inc. (NYSE: GS) today about being charged with civil fraud by the SEC over its role in some mortgage derivatives.  We won’t bother telling you that GS is down over 10% at $164.37 (-10.8%) on 75,000,000 shares as of 2:10 PM EST.  What is more important is [...]

Analyst Outlines Palm Scenario (PALM)

Palm, Inc. (NASDAQ: PALM) is trading up on a positive research call this morning oin the chances of a buyout. RBC has maintained an Outperform rating on Palm with an $11 target.  The firm has said it has a $10 to $14 breakup value and it sees a better chance than not of a deal [...]

AEterna Zentaris Stalls on Secondary (AEZS)

AEterna Zentaris Inc. (NASDAQ: AEZS) is killing the week’s gains after it announced that it has received commitments from institutional investors to purchase $15 million of securities in a registered direct offering for an aggregate of approximately 11.1 million common shares of its capital at a price of $1.35 per share.   The company will issue [...]

Phase Forward Joins Oracle (PFWD, ORCL)

Phase Forward Inc. (NASDAQ: PFWD) is being acquired for $685 million, $17.00 per share cash, by Oracle Corp. (NASDAQ: ORCL)… Oracle announced that it has agreed to acquire the company in a $17.00 per share cash merger.  Oracle said that management and employees are expected to join Oracle as part of Oracle’s Health Sciences Global [...]

AMD Topped Out For Now

Advanced Micro Devices Inc. (NYSE: AMD) returned to profitability with $0.09 in non-GAAP EPS versus an expected loss.  The problem is that the guidance failed to impress. AMD was originally up in the after-hours session, but as has been the case many times its guidance disappointment sent shares from being up to being down.  This [...]

BSX Gets One Right (BSX)

Boston Scientific Corporation (NYSE: BSX) is trading higher after last night’s announcement that it will immediately resume distribution of COGNIS(R) CRT-Ds and TELIGEN(R) ICDs in the U.S. BSX closed last night at $7.14 and the after-hours session saw a gain of 6.4% all the way up to $7.60 on a whopping 8,484,967 after-hours share volume. [...]